DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line

Charles River Laboratories Slashes FY24 Outlook - Update

RTTNews | 328天前

Charles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) reaffirmed its adjusted earnings, revenue growth and organic revenue growth guidance range for the full-year 2024.

RTTNews | 418天前

Charles River Laboratories Narrows FY23 Outlook Range; Q3 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) narrowed its earnings, adjusted earnings, revenue growth and organic revenue growth guidance range for the full-year 2023.

RTTNews | 601天前

Charles River Labs Boosts FY23 Outlook As Q2 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) raised its adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2023, to reflect the strong first-quarter financial performance and expectations for the remainder of the year that are largely consistent with its initial outlook.

RTTNews | 782天前

Charles River Labs Slashes FY22 Outlook; Q2 Adj. EPS Tops Estimates, Revenues Miss

While reporting financial results for the second quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) slashed its earnings, adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2022, due primarily to headwinds associated with the CDMO business, foreign exchange, and interest expense due to the rising interest rate environment.

RTTNews | 1063天前

DURECT Appoints Timothy Papp As New CFO

Biopharmaceutical company DURECT Corp. (DRRX) announced Tuesday the appointment of Timothy Papp as its Chief Financial Officer. Papp brings over 25 years of corporate finance experience to DURECT, including 15 years in the Biopharma sector.

RTTNews | 1092天前

Sensex, Nifty Seen Flat To Higher At Open

Indian shares look set to open higher on Wednesday as reports suggest that the India-U.S. trade deal is in its final stages of negotiations.

RTTNews | 35分钟前

Japanese Market Significantly Lower

The Japanese stock market is significantly lower on Wednesday, extending the sharp losses in the previous session, following the mixed cues from Wall Street overnight. The Nikkei 225 is falling well below the 39,650 level, with weakness in technology and financial stocks as well as mixed performance in most other sectors.

RTTNews | 52分钟前

EURUSD	1.1803	GBPUSD	1.37509	AUDUSD	0.65744
USDJPY	143.522	USDCAD	1.36464	USDCHF	0.79075

Advertisement

DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line